The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitors: A summary from the Institute for Clinical and Econom...

por Agboola, Foluso, Rind, David M, Walton, Surrey M, Herron-Smith, Serina, Quach, Danny, Pearson, Steven D
Publicado 2021

The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy: A Summary from the Institute for Clinical and Economic Review’s California Technology Asse...

por Tice, Jeffrey A., Guzauskas, Gregory F., Hansen, Ryan N., Herron-Smith, Serina, Segel, Celia, Walsh, Judith M. E., Pearson, Steven D.
Publicado 2020

Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New Engl...

por McKenna, Avery, Lin, Grace A, Whittington, Melanie D, Nikitin, Dmitriy, Herron-Smith, Serina, Campbell, Jonathan D, Agboola, Foluso, Pearson, Steven D
Publicado 2023

The effectiveness and value of tirzepatide for type 2 diabetes mellitus: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Publi...

por Nikitin, Dmitriy, Lin, Grace A, Campbell, Jon D, Hansen, Ryan N, Brouwer, Elizabeth, Chen, Yilin, Herron-Smith, Serina, Agboola, Foluso, Pearson, Steven D
Publicado 2022

The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

por Rind, David M, McQueen, R. Brett, Herron-Smith, Serina, Herce-Hagiwara, Belén, Gutierrez, Eric, Campbell, Jon D, Fluetsch, Noemi, Pearson, Steven D
Publicado 2022

JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New Englan...

por Agboola, Foluso, Atlas, Steven J, Brouwer, Elizabeth, Carlson, Josh J, Hansen, Ryan N, Herron-Smith, Serina, Nhan, Emily, Rind, David M, Pearson, Steven D
Publicado 2022

The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Mid...

por Wright, Abigail C, Beaudoin, Francesca L, McQueen, R. Brett, Yeung, Kai, Moradi, Ashton, Herron-Smith, Serina, Gutierrez, Eric, Lin, Grace A, Pearson, Steven D
Publicado 2023